Annual Drug Patent Expirations for DAYVIGO
Dayvigo is a drug marketed by Eisai Inc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has forty-nine patent family members in thirty-two countries.
The generic ingredient in DAYVIGO is lemborexant. One supplier is listed for this compound. Additional details are available on the lemborexant profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
